One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...

New research results now published from Lund University’s MASAI trial are even better than the initial findings from last ...

Eli Lilly (LLY) stock rises as company posts Q4 2024 results, beating expectations with a twofold rise in revenue from weight ...

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...

Explore advancements in women's health through AI, equity, and policy with Mia Keeys of Hologic on I Don’t Care.

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

Despite major advances in artificial intelligence (AI) research for healthcare, the deployment and adoption of AI technologies remain limited in clinical practice. This paper describes the FUTURE-AI ...

AstraZeneca has reaffirmed its commitment to transforming cancer care in Africa, unveiling new initiatives aimed at enhancing early ...

Bourla outlined 2025 priorities, which include improving R&D productivity, achieving margin expansion, and maintaining commercial excellence. He highlighted expectations for nine Phase 3 readouts, 13 ...

In commemoration of World Cancer Day 2025, global biopharmaceutical company AstraZeneca has reinforced its dedication to advancing ...

In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...

World Cancer Day is an opportunity to inspire Scotland’s diverse healthcare innovators to unite for patient equity in the ...